Maximum Dose of Duloxetine
The maximum recommended dose of duloxetine is 120 mg/day, which can be administered as either 60 mg twice daily or 120 mg once daily. 1
FDA-Approved Maximum Dosing
- The FDA label explicitly states that the maximum recommended human dose (MRHD) of duloxetine is 120 mg/day for adolescents and adults. 1
- This 120 mg/day maximum applies across all approved indications including major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain. 1
Dosing Schedule Options
- The 120 mg maximum dose can be given as 60 mg twice daily (the traditional approach studied in clinical trials). 2
- Alternatively, 120 mg once daily has been studied and found safe and tolerable, though twice-daily dosing was more common in earlier trials. 2
Clinical Context for Maximum Dosing
- Most patients achieve therapeutic benefit at 60 mg once daily, which is the target dose for the majority of patients with depression. 2
- Dose escalation to 120 mg/day should be considered when patients show insufficient response at 60 mg/day, though evidence suggests that increasing from 60 mg to 120 mg in non-remitters may not provide additional benefit over continuing 60 mg. 3
- In research settings, duloxetine has been studied at doses up to 400 mg/day (200 mg twice daily), but this far exceeds the approved maximum and is not recommended for clinical practice. 4
Safety Considerations at Maximum Dose
- Rapid dose escalation (60 mg → 90 mg → 120 mg over 2 weeks) is safe and tolerable, with most adverse events occurring at initial 60 mg dosing rather than with subsequent increases. 2
- The most common adverse events at 120 mg include nausea, headache, dry mouth, dizziness, and decreased appetite, but these are typically mild and transient. 2
- Discontinuation rates due to adverse events during acute treatment at doses up to 120 mg range from 12-16%, which is acceptable. 2, 5
- Long-term treatment at 120 mg over 2 years showed modest increases in heart rate (mean 5.9 bpm) and weight (mean 3.1 kg), with no sustained hypertension reported. 2
Important Caveats
- Do not exceed 120 mg/day in clinical practice, as this is the maximum approved dose with established safety data. 1
- In overdose situations, fatal outcomes have been reported with duloxetine doses as low as 1000 mg (approximately 8.3 times the maximum recommended dose). 1
- Duloxetine does not produce clinically significant QTc prolongation, which distinguishes it favorably from some other antidepressants. 6